[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100660188":3},{"organization":4,"outcomesModule":7,"designInfo":65,"detailedDescription":11,"studyPopulation":11,"armGroups":71,"interventions":77,"overallOfficials":82,"centralContacts":85,"locations":93,"responsibleParty":390,"collaborators":11,"id":392,"slug":393,"hasResults":394,"nctId":395,"briefTitle":396,"officialTitle":397,"acronym":11,"eligibilityCriteria":398,"healthyVolunteers":394,"sex":399,"minAge":400,"maxAge":11,"enrollmentInfo":401,"targetDuration":11,"studyType":404,"phases":405,"briefSummary":407,"conditions":408,"keywords":415,"overallStatus":446,"whyStopped":11,"lastUpdateSubmitDate":447,"lastUpdatePostDateStruct":448,"startDateStruct":451,"completionDateStruct":453,"leadSponsor":455,"locationsCount":456},{"fullName":5,"class":6},"Bristol-Myers Squibb","INDUSTRY",{"primaryOutcomes":8,"secondaryOutcomes":22,"otherOutcomes":11},[9,13,15,17,19],{"measure":10,"description":11,"timeFrame":12},"Number of participants with treatment emergent adverse events (TEAEs)",null,"Up to approximately 90 days post BMS-986553 infusion",{"measure":14,"description":11,"timeFrame":12},"Number of participants with serious adverse events (SAEs)",{"measure":16,"description":11,"timeFrame":12},"Number of participants with adverse events of special interest (AESIs)",{"measure":18,"description":11,"timeFrame":12},"Number of participants with clinically significant laboratory abnormalities",{"measure":20,"description":11,"timeFrame":21},"Number of participants with dose limiting toxicities (DLTs) that occur in DLT evaluation period","28 days after first infusion of BMS-986553",[23,26,28,30,34,36,38,40,42,44,47,49,51,53,55,57,59,61,63],{"measure":24,"description":11,"timeFrame":25},"Maximum observed blood concentration (Cmax) of BMS-986553","Up to approximately week 96",{"measure":27,"description":11,"timeFrame":25},"Time of maximum observed blood concentration (Tmax) of BMS-986553",{"measure":29,"description":11,"timeFrame":25},"Area under the curve (AUC) of BMS-986553",{"measure":31,"description":32,"timeFrame":33},"Percentage of participants with interstitial lung disease (ILD) with no worsening of pulmonary function","Worsening is defined as decline of ≥ 10% in absolute forced vital capacity (FVC) from baseline.","Up to approximately week 24",{"measure":35,"description":11,"timeFrame":33},"SLE participants: Percentage of participants achieving definition of remission in SLE (DORIS) remission",{"measure":37,"description":11,"timeFrame":33},"SLE participants: Percentage of participants achieving lupus low disease activity state (LLDAS)",{"measure":39,"description":11,"timeFrame":33},"SLE participants: Change from baseline in urine protein\u002Fcreatinine ratio (UPCR)\u002Fproteinuria",{"measure":41,"description":11,"timeFrame":33},"IIM participants: Proportion of participants achieving myositis response criteria total improvement score (MRC TIS) moderate or major response",{"measure":43,"description":11,"timeFrame":33},"IIM participants: Change from baseline in International Myositis Assessment and Clinical Studies Group (IMACS) outcome measure set for disease activity",{"measure":45,"description":46,"timeFrame":33},"IIM participants: Change from baseline in Cutaneous Dermatomyositis Disease Area & Severity Index (CDASI)","This will be assessed in dermatomyositis participants only within the IIM group.",{"measure":48,"description":11,"timeFrame":33},"SSc participants: Proportion of participants achieving minimal clinically important difference (MCID) of 24% change from baseline of the Modified Rodnan Skin Score (mRSS)",{"measure":50,"description":11,"timeFrame":33},"SSc participants: Change from baseline in Health Assessment Questionnaire-Disability Index (HAQ-DI)",{"measure":52,"description":11,"timeFrame":33},"SSc participants: Proportion of participants achieving Revised Composite Response Index in Systemic Sclerosis (CRISS) 25",{"measure":54,"description":11,"timeFrame":33},"RA participants: Proportion of participants achieving low Disease Activity Score 28 (using CRP) (DAS28-CRP) from baseline",{"measure":56,"description":11,"timeFrame":33},"RA participants: Change from baseline in HAQ-DI",{"measure":58,"description":11,"timeFrame":33},"RA participants: Proportion of participants achieving Simple Disease Activity Index (SDAI) remission at week 24 from baseline",{"measure":60,"description":11,"timeFrame":33},"SjD participants: Proportion of participants achieving Composite of Relevant Endpoints for Sjögren's Syndrome (CRESS) response",{"measure":62,"description":11,"timeFrame":33},"SjD participants: Proportion of participants achieving Sjögren's Tool for Assessing Response (STAR) response",{"measure":64,"description":11,"timeFrame":33},"SjD participants: Proportion of participants achieving EULAR Sjögren's Syndrome Disease Activity Index (ESSDAI) response of 3 or greater points",{"allocation":66,"interventionModel":67,"interventionModelDescription":11,"primaryPurpose":68,"observationalModel":11,"timePerspective":11,"maskingInfo":69},"NA","SINGLE_GROUP","TREATMENT",{"masking":70,"maskingDescription":11,"whoMasked":11},"NONE",[72],{"label":73,"type":74,"description":11,"interventionNames":75},"BMS-986553","EXPERIMENTAL",[76],"Drug: BMS-986553",[78],{"type":79,"name":73,"description":80,"armGroupLabels":81,"otherNames":11},"DRUG","Specified dose on specified days",[73],[83],{"name":5,"affiliation":5,"role":84},"STUDY_DIRECTOR",[86,91],{"name":87,"role":88,"phone":89,"phoneExt":11,"email":90},"BMS Clinical Trials Contact Center www.BMSClinicalTrials.com","CONTACT","855-907-3286","Clinical.Trials@bms.com",{"name":92,"role":88,"phone":11,"phoneExt":11,"email":11},"First line of the email MUST contain NCT # and Site #.",[94,110,123,136,149,162,175,188,201,214,227,236,250,264,276,290,302,314,326,341,353,365,378],{"facility":95,"status":11,"city":96,"state":97,"zip":98,"country":99,"countryCode":100,"cosmosGeoPoint":101,"geoPoint":106,"contacts":107},"Local Institution - 0064","Newport Beach","California","92663","United States","US",{"type":102,"coordinates":103},"Point",[104,105],-117.92895,33.61891,{"lat":105,"lon":104},[108],{"name":109,"role":88,"phone":11,"phoneExt":11,"email":11},"Site 0064",{"facility":111,"status":11,"city":112,"state":113,"zip":114,"country":99,"countryCode":100,"cosmosGeoPoint":115,"geoPoint":119,"contacts":120},"Local Institution - 0001","Worcester","Massachusetts","01655",{"type":102,"coordinates":116},[117,118],-71.80229,42.26259,{"lat":118,"lon":117},[121],{"name":122,"role":88,"phone":11,"phoneExt":11,"email":11},"Site 0001",{"facility":124,"status":11,"city":125,"state":126,"zip":127,"country":99,"countryCode":100,"cosmosGeoPoint":128,"geoPoint":132,"contacts":133},"Local Institution - 0004","Ann Arbor","Michigan","48109",{"type":102,"coordinates":129},[130,131],-83.74088,42.27756,{"lat":131,"lon":130},[134],{"name":135,"role":88,"phone":11,"phoneExt":11,"email":11},"Site 0004",{"facility":137,"status":11,"city":138,"state":139,"zip":140,"country":99,"countryCode":100,"cosmosGeoPoint":141,"geoPoint":145,"contacts":146},"Local Institution - 0013","Saint Paul","Minnesota","55108",{"type":102,"coordinates":142},[143,144],-93.09327,44.94441,{"lat":144,"lon":143},[147],{"name":148,"role":88,"phone":11,"phoneExt":11,"email":11},"Site 0013",{"facility":150,"status":11,"city":151,"state":152,"zip":153,"country":99,"countryCode":100,"cosmosGeoPoint":154,"geoPoint":158,"contacts":159},"Local Institution - 0062","Omaha","Nebraska","68198",{"type":102,"coordinates":155},[156,157],-95.94043,41.25626,{"lat":157,"lon":156},[160],{"name":161,"role":88,"phone":11,"phoneExt":11,"email":11},"Site 0062",{"facility":163,"status":11,"city":164,"state":165,"zip":166,"country":99,"countryCode":100,"cosmosGeoPoint":167,"geoPoint":171,"contacts":172},"Local Institution - 0007","Morristown","New Jersey","07962",{"type":102,"coordinates":168},[169,170],-74.48154,40.79677,{"lat":170,"lon":169},[173],{"name":174,"role":88,"phone":11,"phoneExt":11,"email":11},"Site 0007",{"facility":176,"status":11,"city":177,"state":178,"zip":179,"country":99,"countryCode":100,"cosmosGeoPoint":180,"geoPoint":184,"contacts":185},"Local Institution - 0052","Great Neck","New York","11021",{"type":102,"coordinates":181},[182,183],-73.72846,40.80066,{"lat":183,"lon":182},[186],{"name":187,"role":88,"phone":11,"phoneExt":11,"email":11},"Site 0052",{"facility":189,"status":11,"city":190,"state":191,"zip":192,"country":99,"countryCode":100,"cosmosGeoPoint":193,"geoPoint":197,"contacts":198},"Local Institution - 0008","Philadelphia","Pennsylvania","19104",{"type":102,"coordinates":194},[195,196],-75.16362,39.95238,{"lat":196,"lon":195},[199],{"name":200,"role":88,"phone":11,"phoneExt":11,"email":11},"Site 0008",{"facility":202,"status":11,"city":203,"state":204,"zip":205,"country":99,"countryCode":100,"cosmosGeoPoint":206,"geoPoint":210,"contacts":211},"Local Institution - 0015","Salt Lake City","Utah","84143",{"type":102,"coordinates":207},[208,209],-111.89105,40.76078,{"lat":209,"lon":208},[212],{"name":213,"role":88,"phone":11,"phoneExt":11,"email":11},"Site 0015",{"facility":215,"status":11,"city":216,"state":217,"zip":218,"country":99,"countryCode":100,"cosmosGeoPoint":219,"geoPoint":223,"contacts":224},"Local Institution - 0005","Seattle","Washington","98104",{"type":102,"coordinates":220},[221,222],-122.33207,47.60621,{"lat":222,"lon":221},[225],{"name":226,"role":88,"phone":11,"phoneExt":11,"email":11},"Site 0005",{"facility":228,"status":11,"city":216,"state":217,"zip":229,"country":99,"countryCode":100,"cosmosGeoPoint":230,"geoPoint":232,"contacts":233},"Local Institution - 0003","98109",{"type":102,"coordinates":231},[221,222],{"lat":222,"lon":221},[234],{"name":235,"role":88,"phone":11,"phoneExt":11,"email":11},"Site 0003",{"facility":237,"status":11,"city":238,"state":11,"zip":239,"country":240,"countryCode":241,"cosmosGeoPoint":242,"geoPoint":246,"contacts":247},"Local Institution - 0029","Leuven","3000","Belgium","BE",{"type":102,"coordinates":243},[244,245],4.70093,50.87959,{"lat":245,"lon":244},[248],{"name":249,"role":88,"phone":11,"phoneExt":11,"email":11},"Site 0029",{"facility":251,"status":11,"city":252,"state":11,"zip":253,"country":254,"countryCode":255,"cosmosGeoPoint":256,"geoPoint":260,"contacts":261},"Local Institution - 0039","Montpellier","34295","France","FR",{"type":102,"coordinates":257},[258,259],3.87635,43.61093,{"lat":259,"lon":258},[262],{"name":263,"role":88,"phone":11,"phoneExt":11,"email":11},"Site 0039",{"facility":265,"status":11,"city":266,"state":11,"zip":267,"country":254,"countryCode":255,"cosmosGeoPoint":268,"geoPoint":272,"contacts":273},"Local Institution - 0047","Paris","75014",{"type":102,"coordinates":269},[270,271],2.3488,48.85341,{"lat":271,"lon":270},[274],{"name":275,"role":88,"phone":11,"phoneExt":11,"email":11},"Site 0047",{"facility":277,"status":11,"city":278,"state":11,"zip":279,"country":280,"countryCode":281,"cosmosGeoPoint":282,"geoPoint":286,"contacts":287},"Local Institution - 0028","Berlin","10117","Germany","DE",{"type":102,"coordinates":283},[284,285],13.41053,52.52437,{"lat":285,"lon":284},[288],{"name":289,"role":88,"phone":11,"phoneExt":11,"email":11},"Site 0028",{"facility":291,"status":11,"city":292,"state":11,"zip":293,"country":280,"countryCode":281,"cosmosGeoPoint":294,"geoPoint":298,"contacts":299},"Local Institution - 0060","Erlangen","91054",{"type":102,"coordinates":295},[296,297],11.00783,49.59099,{"lat":297,"lon":296},[300],{"name":301,"role":88,"phone":11,"phoneExt":11,"email":11},"Site 0060",{"facility":303,"status":11,"city":304,"state":11,"zip":305,"country":280,"countryCode":281,"cosmosGeoPoint":306,"geoPoint":310,"contacts":311},"Local Institution - 0059","Magdeburg","39120",{"type":102,"coordinates":307},[308,309],11.63189,52.13129,{"lat":309,"lon":308},[312],{"name":313,"role":88,"phone":11,"phoneExt":11,"email":11},"Site 0059",{"facility":315,"status":11,"city":316,"state":11,"zip":317,"country":280,"countryCode":281,"cosmosGeoPoint":318,"geoPoint":322,"contacts":323},"Local Institution - 0027","Würzburg","97080",{"type":102,"coordinates":319},[320,321],9.95121,49.79391,{"lat":321,"lon":320},[324],{"name":325,"role":88,"phone":11,"phoneExt":11,"email":11},"Site 0027",{"facility":327,"status":11,"city":328,"state":329,"zip":330,"country":331,"countryCode":332,"cosmosGeoPoint":333,"geoPoint":337,"contacts":338},"Local Institution - 0055","Amsterdam","North Holland","1105 AZ","Netherlands","NL",{"type":102,"coordinates":334},[335,336],4.88969,52.37403,{"lat":336,"lon":335},[339],{"name":340,"role":88,"phone":11,"phoneExt":11,"email":11},"Site 0055",{"facility":342,"status":11,"city":343,"state":11,"zip":344,"country":331,"countryCode":332,"cosmosGeoPoint":345,"geoPoint":349,"contacts":350},"Local Institution - 0063","Leiden","0",{"type":102,"coordinates":346},[347,348],4.49306,52.15833,{"lat":348,"lon":347},[351],{"name":352,"role":88,"phone":11,"phoneExt":11,"email":11},"Site 0063",{"facility":354,"status":11,"city":355,"state":356,"zip":357,"country":358,"countryCode":359,"cosmosGeoPoint":360,"geoPoint":364,"contacts":11},"Local Institution - 0051","Bydgoszcz","Kuyavian-Pomeranian Voivodeship","85-168","Poland","PL",{"type":102,"coordinates":361},[362,363],18.00762,53.1235,{"lat":363,"lon":362},{"facility":366,"status":11,"city":367,"state":368,"zip":369,"country":358,"countryCode":359,"cosmosGeoPoint":370,"geoPoint":374,"contacts":375},"Local Institution - 0050","Krakow","Malopolwksie","30-688",{"type":102,"coordinates":371},[372,373],19.93658,50.06143,{"lat":373,"lon":372},[376],{"name":377,"role":88,"phone":11,"phoneExt":11,"email":11},"Site 0050",{"facility":379,"status":11,"city":380,"state":11,"zip":381,"country":358,"countryCode":359,"cosmosGeoPoint":382,"geoPoint":386,"contacts":387},"Local Institution - 0046","Poznan","60-569",{"type":102,"coordinates":383},[384,385],16.92993,52.40692,{"lat":385,"lon":384},[388],{"name":389,"role":88,"phone":11,"phoneExt":11,"email":11},"Site 0046",{"type":391,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR","100660188","phase-1-a-study-of-bms-986553-in-participants-with-refractory-autoimmune-diseases-100660188",false,"NCT07873931","A Study of BMS-986553 in Participants With Refractory Autoimmune Diseases","A Phase 1, Multicenter, Open-Label Study of BMS-986553, CD19 In Vivo Chimeric Antigen Receptor (CAR) T Cells, in Participants With Refractory Autoimmune Diseases","Inclusion Criteria:\n\n* SLE participants: Must have diagnosis of SLE defined as fulfilling the 2019 ACR\u002FEULAR classification criteria of SLE.\n* IIM participants: Must have diagnosis of IIM defined as fulfilling the 2017 ACR\u002FEULAR classification criteria for probable or definite IIM.\n* SSc participants: Must have diagnosis of SSc defined as fulfilling 2013 ACR\u002FEULAR classification criteria for SSc.\n* RA participants: Must have diagnosis of RA, defined as fulfilling 2010 ACR\u002FEULAR criteria for RA.\n* Primary SjD Participants: Must have diagnosis fulfilling the 2016 ACR\u002FEULAR Classification Criteria.\n\nExclusion Criteria:\n\n* Participants must not have other systemic immune disorders. Other protocol-defined Inclusion\u002FExclusion criteria apply.","ALL","18 Years",{"count":402,"type":403},60,"ESTIMATED","INTERVENTIONAL",[406],"PHASE1","The purpose of this study is to evaluate the safety and tolerability of BMS-986553, CD19 in vivo Chimeric Antigen Receptor (CAR) T cells, in participants with refractory autoimmune diseases including systemic lupus erythematosus (SLE), idiopathic inflammatory myopathies (IIM), systemic sclerosis (SSc), rheumatoid arthritis (RA), and Sjögren's disease (SjD).",[409,410,411,412,413,414],"Systemic Lupus Erythematosus","Sjögren's Disease","Rheumatoid Arthritis","Idiopathic Inflammatory Myopathies","Systemic Sclerosis","Lupus Nephritis",[416,417,418,419,420,421,422,423,424,425,426,427,428,429,430,431,432,433,434,435,436,437,438,439,440,441,442,443,444,445],"CD19 in vivo CART","CAR T","In-vivo CAR T","In-vivo CD19","In-vivo CD19 CAR T","IM065-0002","Refractory autoimmune disease","Autoimmune disease that hasn't responded to treatment","Lupus","Systemic lupus erythematosus","Severe lupus","Lupus kidney disease","Muscle inflammation disease","Myositis","Inflammatory myopathy","Skin and muscle autoimmune disease","Dermatomyositis","Scleroderma","Systemic sclerosis","Skin thickening autoimmune disease","Rheumatoid arthritis","Chronic joint inflammation","Sjögren's disease","Dry eyes and dry mouth autoimmune disease","ILD","Severe autoimmune disease","Interstitial lung disease","Worsening lung disease","Disease caused by harmful antibodies","Organ-threatening autoimmune disease","NOT_YET_RECRUITING","2026-10-08",{"date":449,"type":450},"2026-10-14","ACTUAL",{"date":452,"type":403},"2026-10-30",{"date":454,"type":403},"2033-01-31",{"name":5,"class":6},23]